tag:blogger.com,1999:blog-24549828237003262842024-03-19T15:10:20.322-07:00Holidays on the Islets of LangerhansUnknownnoreply@blogger.comBlogger186125tag:blogger.com,1999:blog-2454982823700326284.post-17726337749165017952011-08-08T13:21:00.000-07:002011-08-08T13:21:15.876-07:00cleanse your liver<span class="Apple-style-span" style="background-color: #b8d7f6;">(NaturalNews) If you experience major, persisting health problems, either physical or emotional, your liver may be congested with toxic compounds that are trapped within clumps of hardened bile (intrahepatic stones. Almost all health conditions, beauty problems and premature aging are closely linked with declined liver performance which most often is elusive to blood tests. Congestion in the bile ducts of the liver undermines the body's effort to make proper use of the food you eat. This, in turn, may lead to numerous physical ailments and accentuated expressions of discomfort, including fear, anger, impatience, greed, depression, dis-ease and cynicism. Cleansing the liver of existing obstructions and impurities can help restore balance, vitality and happiness in every facet of your life.<br />
<br />
When the Body Complains…<br />
<br />
Unlike the stomach, for example, the liver never tells you directly when it is upset or needs special attention. It tells you indirectly, though, when it starts to perform poorly. The following conditions are related to poor liver functions: skin irritation, weak eyesight, unhealthy bowel movements, irregular menstrual cycles, recurring headaches, unexplainable weight gain, loss of energy, sudden aging, elevated cholesterol levels, most allergies, constricted blood vessels, bloated abdomen, fluid retention, gastrointestinal trouble, breathing difficulties, poor memory and concentration, pain in the joints or elsewhere in the body, brittle bones and any other major illness such as heart disease, cancer, MS, diabetes or Alzheimer's disease.<br />
<br />
The liver is responsible for processing, converting, distributing and maintaining the body's fuel supply which consists of nutrients and energy. Impeding these vital functions not only affects the body's performance as a whole, but also the health of every single cell. The liver cannot perform any of these functions properly if its bile ducts are clogged with deposits of hardened bile or "gallstones" (made of gall or bile).<br />
<br />
Gallstones are caused by a number of factors, including the modern fast pace of living, stress, imbalanced diets, disruptive lifestyle, use of medical drugs, stimulants and alcohol, and ingestion of chemical poisons, such as food additives and artificial sweeteners. Bile duct congestion results in major impairment of digestive functions, thereby restricting the nutrient supply to the trillions of cells in the body. This makes gallstones in the liver to be a major cause of physical and emotional illness.<br />
<br />
<strong>The Amazing Liver and Gallbladder Flush</strong><br />
<br />
The liver flush mentioned in this context is a straightforward, safe and painless do-it-yourself procedure using apple juice (or malic acid), olive oil, citrus juice and Epsom salts to dispel gallstones from both the liver and the gallbladder. The actual liver flush takes place within a period of less than fourteen hours and can be taken conveniently over a weekend at home.. Although the liver flush is very easy to do, it is important to understand the process and follow all of the directions precisely.<br />
<br />
Since introducing the liver and gallbladder flush to thousands of patients in the 1990s, I have received countless testimonies expressing total amazement about the fast and profound healing effects it produces. They encouraged me to write a book on the subject. The 200-page book, The Amazing Liver and Gallbladder Flush, includes the exact procedure and necessary background information for conducting this simple, yet most profound cleanse. Today, the liver and gallbladder flush has helped restore the health of hundreds of thousands of people in all parts of the world.<br />
<br />
<strong>Gallstones in the Liver—The Most Common Cause of Illness</strong><br />
<br />
An estimated 20 percent of the world's population will develop gallstones in their gallbladder at some stage in their lives; many of them will opt for surgical removal of this important organ. This statistical figure does not account, though, for the many more people who will develop gallstones (or already have them) in their liver. During some thirty years of practicing natural medicine and dealing with thousands of people suffering from all types of chronic diseases, I can attest to the fact that each one of them, without exception, has had considerable quantities of gallstones in his or her liver. Surprisingly, only relatively few of them reported to have had a history of gallstones in their gallbladder.<br />
<br />
Gallstones in the liver may be the main impediment to acquiring and maintaining good health, youthfulness, and vitality. Gallstones in the liver may, indeed, be one of the major reasons people become ill and have difficulty recuperating from illness.<br />
<br />
<strong>Medicine's Most Unfortunate Oversight</strong><br />
<br />
Many people believe that gallstones can be found only in the gallbladder. This is a commonly made yet false assumption. Most gallstones are actually formed in the liver, and comparatively few occur in the gallbladder. You can easily verify this assessment by giving yourself a liver flush. It matters little whether you are a layperson, a medical doctor, a scientist, or someone whose gallbladder was removed and, therefore, is believed to be stone free. The results of the liver flush speak for themselves. No amount of scientific proof or medical explanation can make such a cleanse any more valuable than it already is. Once you see hundreds of green, beige-colored, brown, or black gallstones floating in the toilet bowl during your first liver flush, you will intuitively know that you are on to something extremely important in your life.<br />
<br />
I am repeatedly asked the intriguing question—why is there only little or no reference in mainstream medicine to the occurrence of gallstones in the liver? Standard clinical tests almost never reveal the occurrence of gallstones in the liver. In fact, most doctors don't even know they grow there. Only some of the most advanced research universities, such as the prestigious Johns Hopkins University, describe and illustrate these liver stones in their literature or on their web sites. They refer to them as "intrahepatic gallstones." The failure to recognize and accept the incidence of gallstone formation in the liver as an extremely common phenomenon may very well be the most unfortunate oversight that has ever been made in the field of medicine, both orthodox and holistic.<br />
<br />
Relying so heavily on blood tests for diagnostic purposes, as conventional medicine does, may actually be a great disadvantage with regard to assessing liver health. Most people who have a physical complaint of one kind or another may show to have perfectly normal liver enzyme levels in the blood, despite suffering from liver congestion. Liver congestion is among the leading health problems, yet conventional medicine rarely refers to it, nor do doctors have a reliable way to detect and diagnose such a condition. Liver enzyme levels in the blood become elevated only when there is advanced liver cell destruction, as is the case, for example, in hepatitis or liver inflammation. Liver cells contain large amounts of enzymes. Once a certain number of liver cells are ruptured, their enzymes will start showing up in the blood. When detected through a blood test, this increased count of liver enzymes indicates abnormal liver functions. In such an event, however, the damage has already occurred. It takes many years of chronic liver congestion before liver damage becomes apparent.<br />
<br />
Unfortunately, unless there is a specific liver disease, this vital organ is rarely considered a "culprit" for other diseases. The majority of gallstones in the liver consist of the same "harmless" constituents as are found in liquid bile, with cholesterol being the main ingredient. A number of stones consist of fatty acids and other organic material that has ended up in the bile ducts. The fact that the majority of these stones are just congealed clumps of bile or organic matter makes them practically "invisible" to x-rays, ultrasonic technologies, and Computer Tomography (CT).<br />
<br />
The situation is different with regard to the gallbladder, where up to about 20 percent of all stones can be made-up entirely of minerals, predominantly, calcium salts and bile pigments. Whereas diagnostic tests can easily detect these hardened, relatively large stones in the gallbladder, they tend to miss the softer, non-calcified stones in the liver. Only when excessive amounts of cholesterol-based stones (85-95% cholesterol) or other clumps of fat block the bile ducts of the liver, may an ultrasound test reveal what is generally referred to as "fatty liver." In such a case, the ultrasound pictures reveal a liver that is almost completely white (instead of black). A fatty liver can gather up to 20,000 stones before it succumbs to suffocation and ceases to function.<br />
<br />
If you had a fatty liver and went to the doctor, he would tell you that you had excessive fatty tissue in your liver. It is less likely, though, that he would tell you that you had intrahepatic gallstones (stones obstructing the liver's bile ducts). As mentioned before, most of the smaller stones in the liver are not detectable through ultrasound or Computer axial Tomography (CT). Nevertheless, careful analysis of diagnostic images by specialists would show whether some of the smaller bile ducts in the liver were dilated because of obstruction. A dilation of bile ducts caused by larger and denser stones or by clusters of stones may be detected more readily through Magnetic Resonance Imaging (MRI). However, unless there is an indication of major liver trouble, doctors rarely check for such intrahepatic stones. Unfortunately, although the liver is one of the most important organs in the body, its disorders are also under-diagnosed all too often.<br />
<br />
Even if the early stages of a fatty liver or gallstone formation in the bile ducts were easily recognized and diagnosed, today's medical facilities offer no treatments to relieve this vital organ of the heavy burden it has to carry.<br />
<br />
On the other hand, a qualified iridologist, an Ayurvedic physician or a natural health practitioner who knows the signs and indications of gallstones in the liver and gallbladder, can easily determine the extent of gallstone formation in these organs. [Such indicators are listed in the book The Amazing Liver and Gallbladder Flush,<a href="http://www.ener-chi.com.]/" style="color: #3366cc; text-decoration: none;" target="_blank">www.ener-chi.com.]</a>Most people in the civilized world have gallstones. But even in alternative or holistic medicine, there is rarely mention of an effective therapy that can actually remove gallstones safely and without pain. Gallstones are a direct product of an unhealthy diet and lifestyle. If gallstones are still present in the liver even after all other disease-causing factors are eliminated, they pose a considerable health risk and may lead to illness and premature aging. By removing these stones, the body as a whole is able to resume its normal, healthy activities.<br />
<br />
<strong>Reaping the Benefits</strong><br />
<br />
People with chronic illnesses often have several thousand gallstones congesting the bile ducts of the liver. Some stones may have also grown in the gallbladder. By removing these stones from these organs through a series of liver flushes and maintaining a balanced diet and lifestyle, the liver and gallbladder can restore their original efficiency, and most symptoms of discomfort or disease in the body can start subsiding. You may find that any persistent allergies will lessen or disappear. Back pain will dissipate, while energy and well-being will improve.<br />
<br />
Sweeping the liver clean eliminates thousands of bits of poisonous substances that have helped form the stones and block thousands of liver bile ducts. Ridding the liver bile ducts from gallstones is one of the most important and powerful procedures you can apply to improve and regain your physical and emotional health. By reopening the bile ducts, the body's energy circuits become restored and healing can take place on all levels of body, mind and spirit.<br />
<span><br />
<br />
Learn more:<a href="http://www.naturalnews.com/022271_liver_gallstones_gallbladder.html#ixzz1UTFUOetp" style="color: #003399; text-decoration: none;">http://www.naturalnews.com/022271_liver_gallstones_gallbladder.html#ixzz1UTFUOetp</a></span></span>Unknownnoreply@blogger.com4tag:blogger.com,1999:blog-2454982823700326284.post-15650126864394409762011-08-08T12:17:00.000-07:002011-08-08T12:17:35.557-07:00Coffee Benefits - Reduce Diabetes risk<a href="http://www.controlstress.net/health-tips/benefits-of-coffee/">Coffee Benefits | Control Stress</a>: "And now there comes word of new medical research indicating that. When compared to those who don’t drink coffee, we dedicated coffee drinkers are probably less likely to have Parkinson’s disease, dementia, or type 2 diabetes. We are also statistically less likely to have certain cancers, problems with heart rhythms and strokes."Unknownnoreply@blogger.com3tag:blogger.com,1999:blog-2454982823700326284.post-49008937700160017352011-07-28T10:15:00.000-07:002011-07-28T10:15:19.199-07:00Glucagonoma - Glucagonoma Causes, Risk Factors, Testing & Treatment<a href="http://www.diabetes.co.uk/glucagonoma.html">Glucagonoma - Glucagonoma Causes, Risk Factors, Testing & Treatment</a>: "Glucagonoma is extremely rare, and occurs when a tumour forms in the islet cells of the pancreas, releasing insulin and glucagon.<br /><br />This type of tumour is usually cancerous, and also usually spreads and becomes more serious over time. Glucagonoma influences the pancreatic islet cells, causing them to produce too much glucagon.<br /><br />How is glucagonoma caused?<br /><br />The causes of glucagonoma are currently unknown. In most cases it is suspected that genetic factors play a strong role. Having family members with multiple endocrine neoplasia type 1 (MEN1) is also regarded as being a risk factor."Unknownnoreply@blogger.com1tag:blogger.com,1999:blog-2454982823700326284.post-33381489536163006492011-07-24T15:04:00.000-07:002011-07-24T15:04:01.094-07:00foodconsumer.org - Alzheimer's disease linked to depression, diabetes and high blood pressure<a href="http://www.foodconsumer.org/newsite/Non-food/Disease/alzheimer_s_disease_linked_to_depression_diabetes_0724110922.html">foodconsumer.org - Alzheimer's disease linked to depression, diabetes and high blood pressure</a>: "health observer suggested so-called risk factors like depression, high blood pressure, diabetes and obesity are actually symptoms. What really causes risk of Alzheimer's disease would be what is causing these symptoms or health conditions. "Unknownnoreply@blogger.com1tag:blogger.com,1999:blog-2454982823700326284.post-37477212286629861912011-07-24T15:02:00.000-07:002011-07-24T15:02:58.227-07:00FDA Data Mining Uncovers Harmful Drug Interaction -- InformationWeekFDA Data Mining Uncovers Harmful Drug Interaction - healthcare Blog<a href="http://www.informationweek.com/news/healthcare/EMR/231002385">FDA Data Mining Uncovers Harmful Drug Interaction -- InformationWeekFDA Data Mining Uncovers Harmful Drug Interaction - healthcare Blog</a>: "Tatonetti, a PhD candidate in 2012, was lead author of a study that appeared in May in the online version of the journal Clinical Pharmacology and Therapeutics that found an interaction between the antidepressant paroxetine (Paxil) and the cholesterol-lowering drug pravastatin (Pravachol) that could put patients at risk of developing diabetes. Taking the two drugs together, Tatonetti and fellow researchers from Stanford, Vanderbilt University, and Harvard University reported, could cause blood glucose levels to spike."Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-2454982823700326284.post-29831292861750948482011-07-24T15:01:00.000-07:002011-07-24T15:01:30.354-07:00Surgeons pioneer new ways to treat di... JPost - Health & Science<a href="http://www.jpost.com/Health/Article.aspx?id=230344">Surgeons pioneer new ways to treat di... JPost - Health & Science</a>: "NewYork-Presbyterian/Columbia is using techniques from weight-loss surgery to improve blood glucose levels and correct a major complication of the disease."Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-2454982823700326284.post-88590374389458237522011-07-23T17:04:00.000-07:002011-07-23T17:04:10.957-07:00writings on the Islets of Langerhans<a href="http://reeley3.blogspot.com/">Writings on the Islets of Langerhans</a> want to read my next novel? I am unveiling the draft plannings in my writing block. Pop along and have a read. It is raw, the grammer is awful, the spellings could be wrong, but the plot is developing day by day. Would love feedback !Unknownnoreply@blogger.com1tag:blogger.com,1999:blog-2454982823700326284.post-64680692726998325982011-07-03T00:42:00.000-07:002011-07-03T00:42:10.733-07:00Daily Nation: - Opinion |Fast foods blamed for spread of diabetes epidemic<a href="http://www.nation.co.ke/oped/Opinion/-/440808/1193192/-/n9ws1pz/-/">Daily Nation: - Opinion |Fast foods blamed for spread of diabetes epidemic</a> The view from Kenya. Truly a worldwide problemUnknownnoreply@blogger.com0tag:blogger.com,1999:blog-2454982823700326284.post-59893269463149385812011-07-01T00:09:00.000-07:002011-07-01T00:09:34.989-07:00Type 2 Diabetes: From Old Dogmas to New Realities - Part 2 - Diabetes Health<a href="http://www.diabeteshealth.com/read/2011/06/28/7199/type-2-diabetes-from-old-dogmas-to-new-realities---part-2/">Type 2 Diabetes: From Old Dogmas to New Realities - Part 2 - Diabetes Health</a>Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-2454982823700326284.post-45534206309157487212011-06-23T23:44:00.000-07:002011-06-23T23:44:29.812-07:00BBC News - Type 2 diabetes in newly diagnosed 'can be reversed'<a href="http://www.bbc.co.uk/news/health-13887909">BBC News - Type 2 diabetes in newly diagnosed 'can be reversed'</a>Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-2454982823700326284.post-78558634642818886992011-06-23T06:29:00.000-07:002011-06-23T06:31:43.964-07:00Bristol Diabetes Pill Faces Safety Hurdle After Early Drugs Tied to Risks <span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 2px; -webkit-border-vertical-spacing: 2px; border-collapse: collapse; color: #333333; font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif; font-size: 14px;"><strong style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: initial initial; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-size: 14px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; vertical-align: baseline;">EAV_BLOG_VER:79843941c6db5c8a</strong></span><br />
<span class="Apple-style-span" style="font-family: Arial, Helvetica, sans-serif; font-size: 14px; line-height: 14px;"></span><br />
<h1 style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: no-repeat no-repeat; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; clear: both; font-size: 30px; line-height: 1.3em; margin-bottom: 12px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; vertical-align: baseline;">Bristol Diabetes Pill Faces Safety Hurdle After Early Drugs Tied to Risks</h1><br />
<span class="Apple-style-span" style="font-family: Georgia, 'Times New Roman', Times, serif; font-size: 14px; line-height: 22px;"></span><br />
<div style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: initial initial; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-family: Arial; font-size: 15px; font-weight: normal; line-height: 1.6em; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 10px; padding-left: 0px; padding-right: 0px; padding-top: 10px; vertical-align: baseline;"><a class="web_ticker" density="sparse" href="http://www.bloomberg.com/apps/quote?ticker=BMY:US" style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: no-repeat no-repeat; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: #0033cc; font-size: 15px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-decoration: none; vertical-align: baseline;" ticker="BMY:US" title="Get Quote" topic_url="http://topics.bloomberg.com/bristol--myers-squibb-co/">Bristol-Myers Squibb Co. (BMY)</a> and <a class="web_ticker" density="full" href="http://www.bloomberg.com/apps/quote?ticker=AZN:LN" style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: no-repeat no-repeat; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: #0033cc; font-size: 15px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-decoration: none; vertical-align: baseline;" ticker="AZN:LN" title="Get Quote" topic_url="http://topics.bloomberg.com/astrazeneca-plc/">AstraZeneca Plc. (AZN)</a>’s new diabetes pill will probably face increased scrutiny from regulators and doctors after two rivals were tied to cancer and heart risks.</div><div style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: initial initial; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-family: Arial; font-size: 15px; font-weight: normal; line-height: 1.6em; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 10px; padding-left: 0px; padding-right: 0px; padding-top: 10px; vertical-align: baseline;">The drug, dapagliflozin, works differently than Takeda Pharmaceutical Co.’s Actos, linked to cancer last week, and <a class="web_ticker" density="full" href="http://www.bloomberg.com/apps/quote?ticker=GSK:LN" style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: no-repeat no-repeat; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: #0033cc; font-size: 15px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-decoration: none; vertical-align: baseline;" ticker="GSK:LN" title="Get Quote" topic_url="http://topics.bloomberg.com/glaxosmithkline-plc/">GlaxoSmithKline Plc (GSK)</a>’s Avandia, tied to heart risks in 2007. While those drugs adjust the hormone that regulates sugar, the new pill helps patients excrete sugar through their urine.</div><div style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: initial initial; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-family: Arial; font-size: 15px; font-weight: normal; line-height: 1.6em; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 10px; padding-left: 0px; padding-right: 0px; padding-top: 10px; vertical-align: baseline;">“Increasingly, people are on the lookout for problems with these drugs,” said Laurence Kennedy, chairman of Cleveland Clinic’s department of endocrinology, diabetes and metabolism, in a telephone interview. “There will always be a market for finding newer and different ways to help control blood sugar, but the newest ways will be under increasing scrutiny.”</div><div style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: initial initial; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-family: Arial; font-size: 15px; font-weight: normal; line-height: 1.6em; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 10px; padding-left: 0px; padding-right: 0px; padding-top: 10px; vertical-align: baseline;">Some analysts say they won’t project sales for dapagliflozin because of the risks posed by Avandia and Actos. Even if approved after a regulatory panel next month, doctors say they will be slow in using the new drug until more is known about long-term safety. A one-year study reported last year found no cancer or heart risks. Two years of data will be reported June 26 at the <a density="full" href="http://professional.diabetes.org/Congress_Display.aspx?TYP=9&CID=82452" rel="external" style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: no-repeat no-repeat; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: #0033cc; font-size: 15px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-decoration: none; vertical-align: baseline;" title="Open Web Site">American Diabetes Association</a> meeting.</div><div style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: initial initial; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-family: Arial; font-size: 15px; font-weight: normal; line-height: 1.6em; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 10px; padding-left: 0px; padding-right: 0px; padding-top: 10px; vertical-align: baseline;">An estimated <a density="full" href="http://diabetes.niddk.nih.gov/dm/pubs/statistics/#fast" rel="external" style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: no-repeat no-repeat; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: #0033cc; font-size: 15px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-decoration: none; vertical-align: baseline;" title="Open Web Site">25.8 million</a> Americans have diabetes, mostly the Type 2 variety linked to being overweight and sedentary, according to the <a density="sparse" href="http://topics.bloomberg.com/national-institutes-of-health/" style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: no-repeat no-repeat; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: #0033cc; font-size: 15px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-decoration: none; vertical-align: baseline;">National Institutes of Health</a>. The disease is caused by an inability to use insulin to break down blood sugar into energy and can increase the risk of heart disease, stroke and kidney damage. Medicines are used to lower sugar levels.</div><h2 style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: no-repeat no-repeat; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-family: Arial; font-size: 18px; font-weight: bold; line-height: 1.3em; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 20px; vertical-align: baseline;">Patients Lost Weight</h2><div style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: initial initial; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-family: Arial; font-size: 15px; font-weight: normal; line-height: 1.6em; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 10px; padding-left: 0px; padding-right: 0px; padding-top: 10px; vertical-align: baseline;">The new drug is being developed jointly by New York-based Bristol-Myers and London-based AstraZeneca. The earlier trial showed it worked better than insulin plus a placebo, and that patients using it lost weight. This is particularly noteworthy because insulin drugs frequently trigger weight gain.</div><div style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: initial initial; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-family: Arial; font-size: 15px; font-weight: normal; line-height: 1.6em; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 10px; padding-left: 0px; padding-right: 0px; padding-top: 10px; vertical-align: baseline;">If approved, dapagliflozin would be the first in a new class of medications, called SGLT2-inhibitors. Similar drugs are also being developed by Johnson & Johnson, of New Brunswick,<a density="full" href="http://topics.bloomberg.com/new-jersey/" style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: no-repeat no-repeat; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: #0033cc; font-size: 15px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-decoration: none; vertical-align: baseline;">New Jersey</a>, Indianapolis-based <a class="web_ticker" density="sparse" href="http://www.bloomberg.com/apps/quote?ticker=LLY:US" style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: no-repeat no-repeat; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: #0033cc; font-size: 15px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-decoration: none; vertical-align: baseline;" ticker="LLY:US" title="Get Quote" topic_url="http://topics.bloomberg.com/eli-lilly-&-co/">Eli Lilly & Co. (LLY)</a> and the German drugmaker Boehringer Ingelheim GmbH, Tokyo-based Astellas Pharma Inc., Isis Pharmaceuticals Inc., based in Carlsbad, <a density="full" href="http://topics.bloomberg.com/california/" style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: no-repeat no-repeat; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: #0033cc; font-size: 15px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-decoration: none; vertical-align: baseline;">California</a>, and Lexicon Pharmaceuticals Inc., of The Woodlands, <a density="full" href="http://topics.bloomberg.com/texas/" style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: no-repeat no-repeat; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: #0033cc; font-size: 15px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-decoration: none; vertical-align: baseline;">Texas</a>.</div><div style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: initial initial; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-family: Arial; font-size: 15px; font-weight: normal; line-height: 1.6em; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 10px; padding-left: 0px; padding-right: 0px; padding-top: 10px; vertical-align: baseline;">The companies, analysts and investors will be closely watching the safety results and a panel of Food and Drug Administration advisers that is set to review dapagliflozin on July 19, said <a density="full" href="http://topics.bloomberg.com/les-funtleyder/" style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: no-repeat no-repeat; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: #0033cc; font-size: 15px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-decoration: none; vertical-align: baseline;">Les Funtleyder</a>, a portfolio manager at Miller Tabak in New York, in a telephone interview.</div><h2 style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: no-repeat no-repeat; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-family: Arial; font-size: 18px; font-weight: bold; line-height: 1.3em; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 20px; vertical-align: baseline;">No Modeling</h2><div style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: initial initial; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-family: Arial; font-size: 15px; font-weight: normal; line-height: 1.6em; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 10px; padding-left: 0px; padding-right: 0px; padding-top: 10px; vertical-align: baseline;">Concerns about potential side effects of all diabetes medications leave analysts little room to assess the sales potential of dapagliflozin, he said.</div><div style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: initial initial; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-family: Arial; font-size: 15px; font-weight: normal; line-height: 1.6em; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 10px; padding-left: 0px; padding-right: 0px; padding-top: 10px; vertical-align: baseline;">“With these type of drugs, we don’t model until they’re approved because so much can go wrong,” Funtleyder said. “We know it’s a new class in diabetes, which is often not well- controlled. The downside is people are nervous about possible infections and other side effects, and you have to take the good with the bad.”</div><div style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: initial initial; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-family: Arial; font-size: 15px; font-weight: normal; line-height: 1.6em; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 10px; padding-left: 0px; padding-right: 0px; padding-top: 10px; vertical-align: baseline;">Bristol-Myers referred comment to AstraZeneca. AstraZeneca’s spokeswoman Kirsten Evraire declined to comment.</div><div style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: initial initial; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-family: Arial; font-size: 15px; font-weight: normal; line-height: 1.6em; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 10px; padding-left: 0px; padding-right: 0px; padding-top: 10px; vertical-align: baseline;">In May, U.S. regulators restricted use of London-based Glaxo’s Avandia, ordering the drug to be pulled from pharmacy shelves and made available only through a special program. Sales of Avandia fell to $680 million last year from $1.8 billion in 2007 after a study that year showed a 43 percent increased risk of heart attacks among patients taking the medicine.</div><div style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: initial initial; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-family: Arial; font-size: 15px; font-weight: normal; line-height: 1.6em; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 10px; padding-left: 0px; padding-right: 0px; padding-top: 10px; vertical-align: baseline;">On June 15, a five-year analysis from a decade-long company-sponsored study of Takeda’s Actos showed an increased risk of bladder cancer. Actos is the world’s biggest-selling diabetes drug. The FDA had required the study under new guidelines for diabetes drug approvals.</div><div style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: initial initial; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-family: Arial; font-size: 15px; font-weight: normal; line-height: 1.6em; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 10px; padding-left: 0px; padding-right: 0px; padding-top: 10px; vertical-align: baseline;">$1.6 billion by 2017</div><div style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: initial initial; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-family: Arial; font-size: 15px; font-weight: normal; line-height: 1.6em; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 10px; padding-left: 0px; padding-right: 0px; padding-top: 10px; vertical-align: baseline;">Bristol-Myers’s and AstraZeneca’s Onglyza and Kombiglyze, a version of the drug combined with metformin, a standard treatment, generated $158 million last year. Those two drugs are projected to make $1.6 billion by 2017, according to estimates from <a density="full" href="http://topics.bloomberg.com/seamus-fernandez/" style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: no-repeat no-repeat; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: #0033cc; font-size: 15px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-decoration: none; vertical-align: baseline;">Seamus Fernandez</a>, an analyst for Leerink Swann.</div><div style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: initial initial; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-family: Arial; font-size: 15px; font-weight: normal; line-height: 1.6em; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 10px; padding-left: 0px; padding-right: 0px; padding-top: 10px; vertical-align: baseline;">Even after approval, “we still have an obligation to conduct studies carefully and properly just to make sure nothing major has been missed” said Kennedy, of the <a density="sparse" href="http://topics.bloomberg.com/cleveland-clinic/" style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: no-repeat no-repeat; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: #0033cc; font-size: 15px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-decoration: none; vertical-align: baseline;">Cleveland Clinic</a>.</div><div style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: initial initial; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-family: Arial; font-size: 15px; font-weight: normal; line-height: 1.6em; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 10px; padding-left: 0px; padding-right: 0px; padding-top: 10px; vertical-align: baseline;">Since its original warning on Avandia, the FDA has required an aftermarket study of heart risks for all diabetes drug applications, said <a density="full" href="http://topics.bloomberg.com/karen-riley/" style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: no-repeat no-repeat; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: #0033cc; font-size: 15px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-decoration: none; vertical-align: baseline;">Karen Riley</a>, a spokeswoman for the FDA, in an e-mail.</div><h2 style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: no-repeat no-repeat; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-family: Arial; font-size: 18px; font-weight: bold; line-height: 1.3em; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 20px; vertical-align: baseline;">‘New Lessons’</h2><div style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: initial initial; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-family: Arial; font-size: 15px; font-weight: normal; line-height: 1.6em; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 10px; padding-left: 0px; padding-right: 0px; padding-top: 10px; vertical-align: baseline;">“Not all programs are identical and development isn’t static so as these data come in, we have to apply new lessons learned to the interpretation of risk assessment for subsequent programs,” she wrote.</div><div style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: initial initial; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-family: Arial; font-size: 15px; font-weight: normal; line-height: 1.6em; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 10px; padding-left: 0px; padding-right: 0px; padding-top: 10px; vertical-align: baseline;">The number of Americans with diabetes is expected to rise to as many as <a density="full" href="http://www.cdc.gov/media/pressrel/2010/r101022.html" rel="external" style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: no-repeat no-repeat; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: #0033cc; font-size: 15px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-decoration: none; vertical-align: baseline;" title="Open Web Site">1 in 3 adults</a> if trends continue, according to the Atlanta-based Centers for Disease Control and Prevention.</div><div style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: initial initial; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-family: Arial; font-size: 15px; font-weight: normal; line-height: 1.6em; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 10px; padding-left: 0px; padding-right: 0px; padding-top: 10px; vertical-align: baseline;">This explosion in cases has spurred the development of at least nine classes of diabetes drugs, some oral and some injectable. Today there are more than 39 diabetes drugs on market, generating about $16.8 billion in U.S. sales in 2010, according to data from research firm IMS Health.</div><div style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: initial initial; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-family: Arial; font-size: 15px; font-weight: normal; line-height: 1.6em; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 10px; padding-left: 0px; padding-right: 0px; padding-top: 10px; vertical-align: baseline;">Only half of diabetes patients have their blood sugar under control, so there’s a need for new medications, said Martin Abrahamson, the chief medical officer of <a density="full" href="http://www.joslin.org/" rel="external" style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: no-repeat no-repeat; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: #0033cc; font-size: 15px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-decoration: none; vertical-align: baseline;" title="Open Web Site">Joslin Diabetes Center</a>, an affiliate of Harvard Medical School in <a density="full" href="http://topics.bloomberg.com/boston/" style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: no-repeat no-repeat; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: #0033cc; font-size: 15px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-decoration: none; vertical-align: baseline;">Boston</a>.</div><div style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: initial initial; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-family: Arial; font-size: 15px; font-weight: normal; line-height: 1.6em; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 10px; padding-left: 0px; padding-right: 0px; padding-top: 10px; vertical-align: baseline;">“Type 2 diabetes being a progressive disease, one drug, a single drug, is unlikely to be a control for glucose levels over many years,” Abrahamson said in a telephone interview. “Usually you add more medications to achieve glucose targets.”</div><h2 style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: no-repeat no-repeat; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-family: Arial; font-size: 18px; font-weight: bold; line-height: 1.3em; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 20px; vertical-align: baseline;">First-Line Therapy</h2><div style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: initial initial; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-family: Arial; font-size: 15px; font-weight: normal; line-height: 1.6em; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 10px; padding-left: 0px; padding-right: 0px; padding-top: 10px; vertical-align: baseline;"><a density="full" href="http://www.nlm.nih.gov/medlineplus/druginfo/meds/a696005.html" rel="external" style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: no-repeat no-repeat; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: #0033cc; font-size: 15px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-decoration: none; vertical-align: baseline;" title="Open Web Site">Metformin</a>, approved for use in the U.S. in 1995, is almost universally accepted as a first-line therapy for diabetes, because it has a long safety record and is cheap, Abrahamson said. Often, though, it’s not enough.</div><div style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: initial initial; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-family: Arial; font-size: 15px; font-weight: normal; line-height: 1.6em; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 10px; padding-left: 0px; padding-right: 0px; padding-top: 10px; vertical-align: baseline;">Many people with <a density="full" href="http://diabetes.niddk.nih.gov/dm/pubs/riskfortype2/" rel="external" style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: no-repeat no-repeat; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: #0033cc; font-size: 15px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-decoration: none; vertical-align: baseline;" title="Open Web Site">Type 2 diabetes</a> are overweight or obese, and have co-existing conditions such as <a density="sparse" href="http://topics.bloomberg.com/heart-disease/" style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: no-repeat no-repeat; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: #0033cc; font-size: 15px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-decoration: none; vertical-align: baseline;">heart disease</a> and high blood pressure, Abrahamson said. Complications associated with the disease also make prescribing tricky, he said.</div><div style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: initial initial; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-family: Arial; font-size: 15px; font-weight: normal; line-height: 1.6em; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 10px; padding-left: 0px; padding-right: 0px; padding-top: 10px; vertical-align: baseline;">Given the difficulty in controlling the disease, doctors remain eager for new medications, even though they are “becoming more gun shy” as dangerous risks are uncovered after the drugs are approved, said <a density="full" href="http://www.diabetes.ucsf.edu/members/robert-rushakoff" rel="external" style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: no-repeat no-repeat; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: #0033cc; font-size: 15px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-decoration: none; vertical-align: baseline;" title="Open Web Site">Robert Rushakoff</a>, medical director for inpatient diabetes at the <a density="full" href="http://topics.bloomberg.com/university-of-california/" style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: no-repeat no-repeat; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: #0033cc; font-size: 15px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-decoration: none; vertical-align: baseline;">University of California</a>, <a density="full" href="http://topics.bloomberg.com/san-francisco/" style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: no-repeat no-repeat; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: #0033cc; font-size: 15px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-decoration: none; vertical-align: baseline;">San Francisco</a>.</div><div style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: initial initial; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-family: Arial; font-size: 15px; font-weight: normal; line-height: 1.6em; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 10px; padding-left: 0px; padding-right: 0px; padding-top: 10px; vertical-align: baseline;">“Given the reality of diabetes and how difficult it is, endocrinologists will be using it right away,” he said in an interview. “I know I’ll be using it right away. It’s easier than teaching someone to inject a medication. It’s a matter of once the drug moves out of studies, how those side-effects appear. More common, more severe or not a big deal?”</div><h2 style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: no-repeat no-repeat; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-family: Arial; font-size: 18px; font-weight: bold; line-height: 1.3em; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 20px; vertical-align: baseline;">Diabetes Association Meeting</h2><div style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: initial initial; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-family: Arial; font-size: 15px; font-weight: normal; line-height: 1.6em; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 10px; padding-left: 0px; padding-right: 0px; padding-top: 10px; vertical-align: baseline;">The data presented at the American Diabetes Association meeting in <a density="full" href="http://topics.bloomberg.com/san-diego/" style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: no-repeat no-repeat; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: #0033cc; font-size: 15px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-decoration: none; vertical-align: baseline;">San Diego</a> is expected to provide new details on dapagliflozin’s safety profile, said <a density="full" href="http://topics.bloomberg.com/tony-butler/" style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: no-repeat no-repeat; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: #0033cc; font-size: 15px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-decoration: none; vertical-align: baseline;">Tony Butler</a>, an analyst with <a density="full" href="http://topics.bloomberg.com/barclays-capital/" style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: no-repeat no-repeat; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: #0033cc; font-size: 15px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-decoration: none; vertical-align: baseline;">Barclays Capital</a> in <a density="sparse" href="http://topics.bloomberg.com/new-york/" style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: no-repeat no-repeat; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: #0033cc; font-size: 15px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-decoration: none; vertical-align: baseline;">New York</a>. He, like Miller Tabak’s Funtleyder, is unwilling to project sales at this point.</div><div style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: initial initial; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-family: Arial; font-size: 15px; font-weight: normal; line-height: 1.6em; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 10px; padding-left: 0px; padding-right: 0px; padding-top: 10px; vertical-align: baseline;">In the one-year study, dapagliflozin was linked to an increased likelihood of urinary tract and genital infections. While that’s a lesser concern than heart or cancer, it has raised red flags.</div><div style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: initial initial; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-family: Arial; font-size: 15px; font-weight: normal; line-height: 1.6em; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 10px; padding-left: 0px; padding-right: 0px; padding-top: 10px; vertical-align: baseline;"><a density="full" href="http://www.hopkinsmedicine.org/doctors/results/directory/profile/1573452/Rita-Rastogi-Kalyani-MD?firstLetter=K" rel="external" style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: no-repeat no-repeat; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; color: #0033cc; font-size: 15px; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 0px; padding-left: 0px; padding-right: 0px; padding-top: 0px; text-decoration: none; vertical-align: baseline;" title="Open Web Site">Rita Rastogi Kalyani</a> an assistant professor of medicine at Johns Hopkins University in Baltimore, said the infections probably occur because the urinary tract is a more hospitable environment for bacteria when patients excrete more sugar in their urine.</div><div style="background-attachment: initial; background-clip: initial; background-color: transparent; background-image: initial; background-origin: initial; background-position: initial initial; background-repeat: initial initial; border-bottom-width: 0px; border-color: initial; border-left-width: 0px; border-right-width: 0px; border-style: initial; border-top-width: 0px; font-family: Arial; font-size: 15px; font-weight: normal; line-height: 1.6em; margin-bottom: 0px; margin-left: 0px; margin-right: 0px; margin-top: 0px; outline-color: initial; outline-style: initial; outline-width: 0px; padding-bottom: 10px; padding-left: 0px; padding-right: 0px; padding-top: 10px; vertical-align: baseline;">“I think as much as we’re excited about new classes of medications, we’re still looking at the older medications first because they’ve been tested over time,” Kalyani said, referring to metformin. “We’ve seen an explosion of classes but we still don’t know about long-term risks.”</div>Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-2454982823700326284.post-16943528993341299642010-02-04T14:49:00.000-08:002011-01-20T06:28:25.944-08:00WARNING<div><br /></div><div><br /></div><div><span class="Apple-style-span" style="font-family: sans-serif; font-size: 12px; line-height: 19px; "><p style="margin-top: 0.4em; margin-right: 0px; margin-bottom: 0.5em; margin-left: 0px; line-height: inherit; ">Dihydrogen monoxide:</p><ul style="line-height: 1.5em; list-style-type: square; margin-top: 0.3em; margin-right: 0px; margin-bottom: 0.5em; margin-left: 1.5em; padding-top: 0px; padding-right: 0px; padding-bottom: 0px; padding-left: 0px; list-style-image: url(http://bits.wikimedia.org/skins-1.5/monobook/bullet.gif); "><li style="margin-bottom: 0.1em; ">is called "<a href="http://en.wikipedia.org/wiki/Hydroxyl" title="Hydroxyl" style="text-decoration: none; color: rgb(0, 43, 184); background-image: none; background-repeat: initial; background-attachment: initial; -webkit-background-clip: initial; -webkit-background-origin: initial; background-color: initial; background-position: initial initial; ">hydroxyl</a> <a href="http://en.wikipedia.org/wiki/Acid" title="Acid" style="text-decoration: none; color: rgb(0, 43, 184); background-image: none; background-repeat: initial; background-attachment: initial; -webkit-background-clip: initial; -webkit-background-origin: initial; background-color: initial; background-position: initial initial; ">acid</a>", the substance is the major component of <a href="http://en.wikipedia.org/wiki/Acid_rain" title="Acid rain" style="text-decoration: none; color: rgb(0, 43, 184); background-image: none; background-repeat: initial; background-attachment: initial; -webkit-background-clip: initial; -webkit-background-origin: initial; background-color: initial; background-position: initial initial; ">acid rain</a>.</li><li style="margin-bottom: 0.1em; ">contributes to the "<a href="http://en.wikipedia.org/wiki/Greenhouse_effect" title="Greenhouse effect" style="text-decoration: none; color: rgb(0, 43, 184); background-image: none; background-repeat: initial; background-attachment: initial; -webkit-background-clip: initial; -webkit-background-origin: initial; background-color: initial; background-position: initial initial; ">greenhouse effect</a>".</li><li style="margin-bottom: 0.1em; ">may cause severe burns.</li><li style="margin-bottom: 0.1em; ">is fatal if inhaled.</li><li style="margin-bottom: 0.1em; ">contributes to the <a href="http://en.wikipedia.org/wiki/Erosion" title="Erosion" style="text-decoration: none; color: rgb(0, 43, 184); background-image: none; background-repeat: initial; background-attachment: initial; -webkit-background-clip: initial; -webkit-background-origin: initial; background-color: initial; background-position: initial initial; ">erosion</a> of our natural landscape.</li><li style="margin-bottom: 0.1em; ">accelerates <a href="http://en.wikipedia.org/wiki/Corrosion" title="Corrosion" style="text-decoration: none; color: rgb(0, 43, 184); background-image: none; background-repeat: initial; background-attachment: initial; -webkit-background-clip: initial; -webkit-background-origin: initial; background-color: initial; background-position: initial initial; ">corrosion</a> and rusting of many metals.</li><li style="margin-bottom: 0.1em; ">may cause electrical failures and decreased effectiveness of automobile brakes.</li><li style="margin-bottom: 0.1em; ">has been found in excised <a href="http://en.wikipedia.org/wiki/Tumor" title="Tumor" style="text-decoration: none; color: rgb(0, 43, 184); background-image: none; background-repeat: initial; background-attachment: initial; -webkit-background-clip: initial; -webkit-background-origin: initial; background-color: initial; background-position: initial initial; ">tumors</a> of terminal <a href="http://en.wikipedia.org/wiki/Cancer" title="Cancer" style="text-decoration: none; color: rgb(0, 43, 184); background-image: none; background-repeat: initial; background-attachment: initial; -webkit-background-clip: initial; -webkit-background-origin: initial; background-color: initial; background-position: initial initial; ">cancer</a> patients.</li></ul>Despite the danger, dihydrogen monoxide is often used:<ul style="line-height: 1.5em; list-style-type: square; margin-top: 0.3em; margin-right: 0px; margin-bottom: 0.5em; margin-left: 1.5em; padding-top: 0px; padding-right: 0px; padding-bottom: 0px; padding-left: 0px; list-style-image: url(http://bits.wikimedia.org/skins-1.5/monobook/bullet.gif); "><li style="margin-bottom: 0.1em; ">as an industrial solvent and coolant.</li><li style="margin-bottom: 0.1em; ">in nuclear power plants.</li><li style="margin-bottom: 0.1em; ">in the production of Styrofoam.</li><li style="margin-bottom: 0.1em; ">as a fire retardant.</li><li style="margin-bottom: 0.1em; ">in many forms of cruel animal research.</li><li style="margin-bottom: 0.1em; ">in the distribution of pesticides. Even after washing, produce remains contaminated by this chemical.</li><li style="margin-bottom: 0.1em; ">as an additive in certain "junk-foods" and other food products.</li></ul><div><span class="Apple-style-span" style="line-height: 18px;"><br /></span></div><div><span class="Apple-style-span" style="line-height: 18px;"><br /></span></div><div><span class="Apple-style-span" style="line-height: 18px;">You MUST avoid this dangerous substance. It is found in domestic kitchens and bathrooms, swimming areas and bathing locations, and also comes in bottles from shops and other retail outlets, rarely if ever is a caution label attached, it may be labelled as '"Sparkling", "Still", or "Flavoured".</span></div></span></div>Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-2454982823700326284.post-51587304211450982522010-01-26T23:58:00.000-08:002011-01-20T06:28:25.961-08:00Very Interesting topic reported by the <a href="http://news.bbc.co.uk/2/hi/health/8481770.stm">BBC.</a> Interestingly I had read reports that indicated that a lower blood glucose level was target to achieve. I think that this adds a bit od 'sense' - the right blood sugar level is what we should aim for. I aim for around 7, but achieve around 7.5<br /><br /><br />Diabetes sugar 'can go too low'<br /><br />Diabetes disrupts blood sugar levels<br />Intense treatment to lower blood sugar in patients with diabetes could prove nearly as harmful as allowing glucose levels to remain high, a study says.<br />Cardiff researchers looked at nearly 50,000 patients with type 2 diabetes and found the lowest glucose levels linked to a heightened risk of death.<br />Significant differences in death rates between patients on insulin and those taking tablets are also flagged up.<br />But there could be various explanations for this, experts noted.<br />Patients taking insulin-based treatments have been urged not to stop taking their medication as a result of the Cardiff University study, which is published in The Lancet.<br />Changing treatments<br />Using data from GPs, the team identified 27,965 patients with type 2 diabetes whose treatment had been intensified to include two oral blood glucose lowering agents - metformin and sulphonylurea.<br />It is crucial to remember that blood glucose targets should always be agreed by the person with diabetes and their healthcare team according to individual needs and not according to a blanket set of rules<br />Dr Iain FrameDiabetes UK<br />A further 20,005 patients who had been moved on to treatment which included insulin were added to the study.<br />Patients whose HbA1c levels - the proportion of red blood cells with glucose attached to them - were around 7.5%, ran the lowest risk of dying from any cause.<br />For both groups this risk went up by more than half if levels dropped to 6.4%, the lowest levels recorded. For those with the highest levels the risk of death increased by nearly 80%.<br />But the risks appeared to be particularly pronounced among those on the insulin-based regimen than those on the combined treatment.<br />Irrespective of whether their HbA1c levels were low or high, there were 2,834 deaths in the insulin-taking group between 1986 and 2008, nearly 50% more than in the combined group.<br />'Don't stop'<br />The authors acknowledged there could be various factors associated with this, such as these being older patients with more health problems, who perhaps had had diabetes for a longer period of time. They also make reference to a possible link between use of insulin and cancer progression that had been reported in a different study.<br />"Whether intensification of glucose control with insulin therapy alone further heightens risk of death in patients with diabetes needs further investigation and assessment of the overall risk balance," wrote lead author Dr Craig Currie.<br />"Low and high mean HbA1c values were associated with increased all-cause mortality and cardiac events. If confirmed, diabetes guidelines might need revision to include a minimum HbA1c value."<br />Dr Iain Frame, head of research at Diabetes UK, described the study as "potentially important" but stressed it had limitations.<br />"It is not clear what the causes of death were from the results reported. Furthermore, when it comes to the suggestion made in this research that insulin could increase the risk of death, we must consider important factors such as age, the duration of their diabetes and how the participants managed their condition.<br />"It is crucial to remember that blood glucose targets should always be agreed by the person with diabetes and their healthcare team according to individual needs and not according to a blanket set of rules."<br />While people would be able to manage their condition for a period with diet, exercise and even tablets, many would eventually have to move on to insulin, he noted.<br />"We would advise people with type 2 diabetes who use insulin not to stop taking their medication. However, if they are worried about blood glucose targets, they should discuss this with their healthcare team."Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-2454982823700326284.post-49841649830417782382010-01-07T23:51:00.000-08:002011-01-20T06:28:25.979-08:00Obvious to some, but perhaps not to all. Here is some very good advice from <a href="http://health.yahoo.com/diabetes-living/sick-day-guidelines-for-people-with-diabetes/healthwise--uq2659spec.html">Yahoo Health </a>on handling illness when you already have diabetes<br /><br />What happens when you are sick<br />When you are sick, your body reacts by releasing <a href="http://health.yahoo.com/diabetes-living/hormones/healthwise--sth149942.html">hormones</a> to fight infection. But these hormones raise blood sugar levels and at the same time make it more difficult for <a href="http://health.yahoo.com/diabetes-living/insulin/healthwise--sti150726.html">insulin</a> to lower blood sugar. When you have <a href="http://health.yahoo.com/diabetes-living/diabetes/healthwise--std120744.html">diabetes</a>, even a minor illness can lead to dangerously high blood sugar. This may cause life-threatening complications, such as <a href="http://health.yahoo.com/diabetes-living/diabetic-ketoacidosis/healthwise--std120862.html">diabetic ketoacidosis</a> or a <a href="http://health.yahoo.com/diabetes-living/hyperosmolar-state/healthwise--uq2875.html">hyperosmolar state</a>.<br />Plan ahead<br />Work with your doctor to make a sick-day plan for you or your child with diabetes. Discuss your target blood sugar goal during an illness, how you should adjust your insulin dose and timing (if you take insulin), and when you need to contact your doctor for help. Also, make sure you know how often to check blood sugar and urine ketone levels. Keep your plan in a convenient place, and include contact information in case you need to reach your doctor at night or on the weekends.<br />Steps to take during an illness<br />Here are some general sick-day guidelines:<br />Continue taking your pills for diabetes (if you have <a href="http://health.yahoo.com/diabetes-living/type-2-diabetes/healthwise--stt11174.html">type 2 diabetes</a>) or insulin, even if you are vomiting and having trouble eating or drinking. Your blood sugar may continue to rise because of your illness. If you cannot take your medicines, call your doctor and discuss whether you need to adjust your insulin dose or other medicine.<br />Try to eat your normal types and amounts of food and to drink extra fluids, such as water, broth, carbonated drinks, and fruit juice. Encourage your child to drink extra liquids to prevent <a href="http://health.yahoo.com/diabetes-living/dehydration/healthwise--std120726.html">dehydration</a>.<br />If your blood sugar level is higher than 240 milligrams per deciliter (mg/dL), drink extra liquids that do not contain sugar, such as water or sugar-free cola.<br />If you cannot eat the foods in your regular diet, drink extra liquids that contain sugar and salt, such as soup, sports drinks, or milk. You may also try eating foods that are gentle on the stomach, such as crackers, gelatin, or applesauce. Try to eat or drink 50 grams (g) of carbohydrate every 3 to 4 hours. For example, 6 saltine crackers, 1 cup (8 fl oz) of milk, and ½ cup (4 fl oz) of orange juice each contain approximately 15 g of carbohydrate.<br />Check your blood sugar at least every 3 to 4 hours, or more often if it is rising quickly, even through the night. If your blood sugar level rises above 240 mg/dL and your doctor has told you to take an extra insulin dose for high blood sugar levels, take the appropriate amount. If you take insulin and your doctor has not told you to take a specific amount of additional insulin, call him or her for advice.<br />If you take insulin, do a <a href="http://health.yahoo.com/diabetes-living/urine-test-for-ketones/healthwise--aa111279.html">urine test for ketones</a> every 6 to 12 hours, especially if your blood sugar is higher than 300 mg/dL. Call your doctor if you have more than 2+ or moderate ketones in your urine. Check your child's urine for ketones at least every 6 hours, even through the night.<br />Weigh yourself and check your temperature, breathing rate, and pulse frequently if your blood sugar is higher than 300 mg/dL. If you are losing weight and your temperature, breathing rate, and pulse are increasing, contact a doctor. You may be getting worse.<br />Don't take any <a href="http://health.yahoo.com/diabetes-living/nonprescription-medicines/healthwise--hw38934.html">nonprescription medicines</a> without talking with your doctor. Many nonprescription medicines affect your blood sugar level.<br />When to call your doctor<br />Minor illnesses in people with diabetes—especially children with <a href="http://health.yahoo.com/diabetes-living/type-1-diabetes/healthwise--stt11221.html">type 1 diabetes</a>—can lead to very high blood sugar levels and possible emergencies. When children are sick, watch them closely for signs that they need immediate medical attention. Call 911 or other emergency services if you or your child has:<br />Symptoms of diabetic ketoacidosis (DKA), such as abdominal pain, vomiting, rapid breathing, fruity-smelling breath, or severe drowsiness.<br />Symptoms of dehydration, such as a dry mouth and very yellow or dark urine. Dehydration is particularly dangerous in <a href="http://health.yahoo.com/diabetes-living/children/healthwise--not60109.html">children</a> and may be caused by vomiting and diarrhea.<br />A low blood sugar level that continues.<br />It may not be necessary to call your doctor every time you or your child with diabetes has a mild illness, such as a cold. But it is a good idea to call for advice when you are sick and:<br />Your blood sugar level is higher than 240 mg/dL after taking the adjusted amount of insulin in your sick-day plan.<br />You take oral diabetes medicine and your blood sugar level is higher than 240 mg/dL before meals and stays high for more than 24 hours.<br />You have more than 2+ or moderate ketones in your urine.<br />You still have a fever and are not feeling better after a few days.<br />You are vomiting or having diarrhea for more than 6 hours.<br />When you are sick, write down the medicine(s) you have been taking and whether you have changed the dosage of your diabetes medicines based on your sick-day plan. Also note changes in your body temperature, weight, blood sugar, and urine ketone levels. Have this information handy when you talk to your doctor.<br /><a name="uq2659spec-credits"></a><a name="Credits"></a><br />Credits<br />Author<br />Caroline Rea, RN, BS, MS<br />Editor<br />Susan Van Houten, RN, BSN, MBA<br />Associate Editor<br />Tracy Landauer<br />Associate Editor<br />Pat Truman, MATC<br />Primary Medical Reviewer<br />Michael J. Sexton, MD - Pediatrics<br />Specialist Medical Reviewer<br />Stephen LaFranchi, MD - Pediatrics and Pediatric Endocrinology<br />Last Updated<br />December 3, 2008Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-2454982823700326284.post-64051832051731703042009-12-28T22:32:00.000-08:002011-01-20T06:28:25.997-08:00Don't lose your feet! A <a href="http://news.bbc.co.uk/1/hi/health/8427937.stm">report from the BBC </a> shows that there is an increase in the number of amputations through diabetes type 2. It is so important to keep on top of your diabetes and to get your blood sugar and cholesterol under control. If you don't then you are at best self mutilating or at worst committing very slow suicide.Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-2454982823700326284.post-59675949196165415822009-12-14T22:49:00.000-08:002011-01-20T06:28:26.016-08:00It seems that just a few cups of tea or coffee a day can help stave off diabetes.<br /><br /><a href="http://news.bbc.co.uk/2/hi/health/8411605.stm">This is from the BBC </a><br />Tea and coffee drinkers have a lower risk of developing type 2 diabetes, a large body of evidence shows.<br />And the protection may not be down to caffeine since decaf coffee has the greatest effect, say researchers in Archives of Internal Medicine.<br />They looked at 18 separate studies involving nearly 500,000 people.<br />This analysis revealed that people who drink three or four cups of coffee or tea a day cut their risk by a fifth or more, say researchers.<br />The same amount of decaffeinated coffee had an even bigger effect, lowering risk by a third.<br />Type 2 diabetes usually starts after the age of 40 and develops when the body can still make some insulin, but not enough, or when the insulin that is produced does not work properly. Type 2 diabetes is treated with a healthy diet and increased physical activity. In addition to this, medication and/or insulin is often required.<br />The identification of the active components of these beverages would open up new therapeutic pathways for the primary prevention of diabetes mellitus<br />The study authors<br />If the findings prove true, doctors may well start advising people to put the kettle on as well as take more exercise and watch their weight, say the researchers.<br />When the authors combined and analysed the data, they found that each additional cup of coffee consumed in a day cut diabetes risk by 7%.<br />Lead researcher Dr Rachel Huxley, from the University of Sydney in Australia, said because of the finding with decaffeinated coffee, the link is unlikely to be solely related to caffeine.<br />Instead, other compounds in coffee and tea - including magnesium and antioxidants known as lignans or chlorogenic acids - may be involved.<br />Special brew<br />"The identification of the active components of these beverages would open up new therapeutic pathways for the primary prevention of diabetes mellitus.<br />"If such beneficial effects were observed in interventional trials to be real, the implications for the millions of individuals who have diabetes mellitus, or who are at future risk of developing it, would be substantial."<br />Dr Victoria King, of Diabetes UK, said: "Without full information about what other factors may be influencing the type 2 diabetes risk of the studies' participants - such as their physical activity levels and diet - as well as what the active ingredient in tea or coffee appears to be, we cannot be sure what, if anything, this observed effect is down to.<br />"What we can be sure of is that the development of type 2 diabetes is strongly linked to lifestyle, which means that many cases could be prevented by keeping active and eating a healthy balanced diet that is low in fat, salt and sugar with plenty of fruit and vegetables."<br /><br /><br /><br /><br /><a href="http://archinte.ama-assn.org/cgi/content/abstract/169/22/2053?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&fulltext=coffee&searchid=1&FIRSTINDEX=0&resourcetype=HWCIT">This press release is an announcement from the Archives of Internal Medicine</a><br /><br /><br />CHICAGO - Individuals who drink more coffee (regular or decaffeinated) or tea appear to have a lower risk of developing <a class="internal" href="http://www.diabeteshealth.com/browse/community/type-2-issues/">type 2 diabetes</a>, according to an analysis of previous studies reported in the December 14/28 issue of Archives of Internal Medicine. A previously published meta-analysis suggested drinking more coffee may be linked with a reduced risk, but the amount of available information has more than doubled since.<br />By the year 2025, approximately 380 million individuals worldwide will be affected by <a class="internal" href="http://www.diabeteshealth.com/browse/community/type-2-issues/">type 2</a> diabetes, according to background information in the article. "Despite considerable research attention, the role of specific dietary and lifestyle factors remains uncertain, although obesity and physical inactivity have consistently been reported to raise the risk of diabetes mellitus," the authors write.<br />Rachel Huxley, D.Phil, of The George Institute for International Health, University of Sydney, Australia, and colleagues identified 18 studies involving 457,922 participants and assessing the association between coffee consumption and diabetes risk published between 1966 and 2009. Six studies involving 225,516 individuals also included information about decaffeinated coffee, whereas seven studies with 286,701 participants reported on tea consumption.<br />When the authors combined and analyzed the data, they found that each additional cup of coffee consumed in a day was associated with a 7 percent reduction in the excess risk of diabetes. Individuals who drank three to four cups per day had an approximately 25 percent lower risk than those who drank between zero and two cups per day.<br />In addition, in the studies that assessed decaffeinated coffee consumption, those who drank more than three to four cups per day had about a one-third lower risk of diabetes than those who drank none. Those who drank more than three to four cups of tea had a one-fifth lower risk than those who drank no tea.<br />"That the apparent protective effect of tea and coffee consumption appears to be independent of a number of potential confounding variables raises the possibility of direct biological effects," the authors write. Because of the association between decaffeinated coffee and diabetes risk, the association is unlikely to be solely related to caffeine. Other compounds in coffee and tea-including magnesium, antioxidants known as lignans or chlorogenic acids-may be involved, the authors note.<br />"If such beneficial effects were observed in interventional trials to be real, the implications for the millions of individuals who have diabetes mellitus, or who are at future risk of developing it, would be substantial," they conclude. "For example, the identification of the active components of these <a class="internal" href="http://www.diabeteshealth.com/browse/food/beverages/">beverages</a> would open up new therapeutic pathways for the primary prevention of diabetes mellitus. It could also be envisaged that we will advise our patients most at risk for diabetes mellitus to increase their consumption of tea and coffee in addition to increasing their levels of physical activity and <a class="internal" href="http://www.diabeteshealth.com/browse/fitness/weight-loss/">weight loss</a>."Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-2454982823700326284.post-8932516352814379682009-12-12T00:16:00.000-08:002011-01-20T06:28:26.033-08:00Have diabetes and fed up with people who don't have diabetes 'sticking their oar in' whether in a kind meaning way or not? Yeah, so was Dr Polonsky and he came up with some diabetes etiquette which I am happy to share with you. Feel free to share with your non diabetic friends :)<br /><br /><br /><p><strong>Here are Dr. Polonsky's 10 etiquette tips for people <em>without</em></strong><strong> diabetes, written from the perspective of someone <em>with</em></strong><strong> diabetes:</strong></p> <ul><li><strong>1 - DON'T </strong>offer unsolicited advice about my eating or other aspects of diabetes. You may mean well, but giving advice about someone's personal habits, especially when it is not requested, isn't very nice. Besides, many of the popularly held beliefs about diabetes ("you should just stop eating sugar") are out of date or just plain wrong.</li><li><strong>2 - DO</strong> realize and appreciate that diabetes is hard work. Diabetes management is a full-time job that I didn't apply for, didn't want, and can't quit. It involves thinking about what, when, and how much I eat, while also factoring in <a href="http://www.diabeteshealth.com/browse/fitness/exercise/" class="internal">exercise</a>, medication, stress, <a href="http://www.diabeteshealth.com/browse/monitoring/blood-sugar/" class="internal">blood sugar</a> monitoring, and so much more - each and every day.</li><li><strong>3 - DON'T</strong> tell me horror stories about your grandmother or other people with diabetes you have heard about. Diabetes is scary enough, and stories like these are not reassuring! Besides, we now know that with good management, odds are good you can live a long, healthy, and happy life with diabetes.</li><li><strong>4 - DO</strong> offer to join me in making healthy lifestyle changes. Not having to be alone with efforts to change, like starting an exercise program, is one of the most powerful ways that you can be helpful. After all, healthy lifestyle changes can benefit everyone!</li><li><strong>5 - DON'T</strong> look so horrified when I check my blood sugars or give myself an injection. It is not a lot of fun for me either. Checking blood sugars and taking medications are things I must do to manage diabetes well. If I have to hide while I do so, it makes it much harder for me.</li><li><strong>6 - DO</strong> ask how you might be helpful. If you want to be supportive, there may be lots of little things I would probably appreciate your help with. However, what I really need may be very different than what you think I need, so please ask first.</li><li><strong>7 - DON'T</strong> offer thoughtless reassurances. When you first learn about my diabetes, you may want to reassure me by saying things like, "Hey, it could be worse; you could have cancer!" This won't make me feel better. And the implicit message seems to be that diabetes is no big deal. However, diabetes (like cancer) IS a big deal.</li><li><strong>8 - DO</strong> be supportive of my efforts for self-care. Help me set up an environment for success by supporting healthy food choices. Please honor my decision to decline a particular food, even when you really want me to try it. You are most helpful when you are not being a source of unnecessary temptation.</li><li><strong>9 - DON'T</strong> peek at or comment on my blood glucose numbers without asking me first. These numbers are private unless I choose to share them. It is normal to have numbers that are sometimes too low or too high. Your unsolicited comments about these numbers can add to the disappointment, frustration, and anger I already feel.</li><li><strong>10 - DO</strong> offer your love and encouragement. As I work hard to manage diabetes successfully, sometimes just knowing that you care can be very helpful and motivating.</li></ul>Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-2454982823700326284.post-57343894484899417552009-12-06T23:25:00.000-08:002011-01-20T06:28:26.047-08:00<span style="font-size:180%;">Understanding Blood Glucose levels</span><br /><br /><br />So you are newly diagnosed as a diabetic and you know that you have to monitor your blood sugar levels, and you know this because the Doctor told you that.<br /><br />But what you don’t know is what it actually means. This should help.<br /><br /><br />Blood sugar concentration, (or in reality glucose level), refers to the amount of glucose present in your blood. Normally the blood glucose level is maintained at a reference range between about 3.6 and 5.8 mM (mmol/l). It is tightly regulated as a part of metabolic homeostasis.<br /><br />WTF? Exactly what does that mean?<br /><br />metabolic homeostasis basically means keeping (or regulating) the internal systems so as to keep a stable condition.<br /><br />Mmol/L is the standard unit of measurement and refers to micro moles per litre and you don’t need to understand the chemistry but in case you want to know:<br /><br />SCIENCE BIT:<br />Average normal blood glucose levels in humans are about 5mM (mmol/l) this is because the molecular weight of glucose, C6H12O6, is about 180 g/mol). The total amount of glucose normally in circulating human blood is about 3.3 to 7g – because an average human contains about 5 litres of blood. (That is just over a gallon in old money). Glucose levels vary a little during the day, rising after meals for an hour or two by a few grams and are usually lowest in the morning, before the first meal of the day (unless you are a secret midnight snacker).<br /><br /><br />So, what is this GLUCOSE stuff? Well it is carried by the bloodstream from the intestines or liver to body cells, it is the primary source of energy for body's cells, fats and oils (ie, lipids) being primarily a compact energy store, kind of like a battery. It really doesn’t mean that you should stop eating sugar, it means that you need to better control the type of food that you eat. But that is a separate story.<br /><br />Failure to maintain blood glucose in the normal range leads to conditions of persistently high (hyperglycemia) or low (hypoglycemia) blood sugar. And that means that your body is not maintaining metabolic homeostasis.<br /><br />A diabetic fails to maintain metabolic homeostasis and normally is hyperglycaemic and has very high glucose levels and this is often characterised by a constant thirst, with the resultant frequent trips to the loo.<br /><br />Earlier on in treatment, a diabetic may also start to suffer hypoglycaemic attacks. This is often because the medication has not returned the body to stability and may well be over compensating.<br /><br />So, at first, you really need to monitor your blood glucose levels, and map it against the food that you eat. That way you can see the effects of what you eat and the medication that you take.<br /><br />As Alexandr would say ‘Simples’Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-2454982823700326284.post-77131306255693665162009-12-06T02:50:00.000-08:002011-01-20T06:28:26.062-08:00<a href="http://www.guardian.co.uk/lifeandstyle/besttreatments/2009/dec/04/doctors-warned-over-common-diabetes-drugs">More on the drug scare - a good explanation I thought</a><br /><br /><p>A group of drugs commonly used for diabetes carry an increased risk of heart problems and death when compared with a different type of diabetes drug, researchers have found. </p><p>Their study found that people taking drugs called sulphonylureas are more likely to have heart attacks, heart failure or die, compared to people taking another popular diabetes drug called metformin. Doctors should choose metformin when treating people with diabetes, unless they can't take it or it doesn't work for them, say the researchers.</p><h2>What do we know already?</h2><p>If you have type 2 diabetes, it means you have too much glucose in your blood. This can damage your blood vessels, causing heart attacks and strokes, as well as damage to smaller blood vessels in your kidneys, feet, and eyes. Some people with type 2 diabetes control their blood glucose through diet and exercise, but most people need diabetes medicines.</p><p>The most commonly used drugs are metformin (brand name Glucophage), and a group of medicines called sulphonylureas. Sulphonyureas include the medicines chlorpropamide, glimepiride (Amaryl), glipizide (Glibenese, Minodiab), tolbutamide, glibenclamide (Daonil, Euglucon), and gliclazide (Diamicron).</p><p>Another group called glitazones (also known as thiazolidinediones) are also used. There are two types: rosiglitazone (Avandia) and pioglitazone (Actos).</p><p>These medicines all help keep your blood glucose under control, although they work in different ways.</p><p>Lately, there's been concern that some of these drugs might increase your chances of having a heart attack or getting heart failure (where the heart can't pump blood efficiently). It's hard to pick up these problems in the clinical studies that are done before drugs are licensed, because they may take a long time to happen, and you need to test very large groups of people to pick up these sorts of differences in risk.</p><p>This new study looked at the risks of having a heart attack, getting heart failure, or dying for any reason while taking one or more of the commonly used diabetes drugs. The researchers used figures from a big database of prescribing information, cross-checked with patient records. They compared each type of drug with metformin, because metformin is a well-established diabetes drug that tends to be used first for people with diabetes.</p><h2>What does the new study say?</h2><p>The study found that people were more likely to die of any cause, or to get heart failure, while taking a sulphonylurea drug, compared with while taking metformin. They were also more likely to have a heart attack, although this link was not as strong.</p><p>It's hard to say exactly how big the difference is. That's because the researchers analysed the results in different ways. Using one set of calculations, the researchers said sulphonylureas were linked to a 60 percent increased risk of death, while using another set, the increased risk was 24 percent.</p><p>Of the two glitazone drugs, pioglitazone seemed to be better than rosiglitazone, although the researchers say they need to see more studies to be sure of this. People were less likely to die of any cause while taking pioglitazone, compared with while taking rosiglitazone or metformin. Neither pioglitazone nor rosiglitazone was linked to more deaths or heart attacks than metformin, although rosiglitazone was linked to an increased chance of heart failure. Doctors are already warned not to prescribe rosiglitazone for people at risk of heart failure.</p><p>It's important to remember that the study didn't compare the drugs with no treatment. So, it didn't say that people were more likely to die while taking sulphonylureas compared with taking nothing at all. The study may simply show that metformin works better than sulphonylureas.</p><h2>How reliable are the findings?</h2><p>The good points of this study are that it covered a lot of people (more than 90,000) over an average of 7 years each. Because of the way the data was recorded, we can compare the risks and benefits of treatments as they're actually prescribed, taking account of the fact that people tend to take more than one drug, or move from one drug to another over time.</p><p>However, this makes it harder to account for all the different factors that could affect the results. For example, people might only take sulphonylurea drugs after they'd tried metformin, and it hadn't worked well enough for them, or because they have kidney disease (people with kidney disease can't take metformin). That might mean that people who took sulphonylureas were sicker than people who took metformin, so more likely to die of any cause.</p><p>Also, the study relies on all the information on the databases being correctly entered at the time. Because this was a 'real world' study, rather than set up by researchers from the start, there's likely to be more human error in terms of recording data than in a clinical trial.</p><h2>Where does the study come from?</h2><p>The study was done by a team of researchers based at Imperial College in London, UK. It was published in the BMJ (British Medical Journal). The study was not directly funded by anyone, although some of the researchers received grants from various research programmes.</p><h2>What does this mean for me?</h2><p>If you are taking a sulphonylurea drug, the results of the study might sound alarming. But they may be less alarming than they sound. The study doesn't show that these drugs are actively doing you harm. If they reduce your glucose levels, they protect you against potential problems with your eyes, nerve endings, and feet, as well as treating symptoms such as thirst and tiredness.</p><p>What the study shows is that they may not be reducing your overall risk of having a heart attack, heart failure, or dying for any other reason, compared with metformin. Previous studies have shown that metformin seems to reduce the chances of having a heart attack or dying in people with diabetes, especially if you're overweight.</p><p>Doctors in the UK are advised to prescribe metformin first for patients with diabetes, although they are told to consider a sulphonylurea in some groups of patients. According to national guidelines, sulphonylureas work faster, so may be used when a quick treatment is needed, and may also be more suitable for patients who are not overweight.</p><h2>What should I do now?</h2><p>All diabetes medicines protect against the problems you get from having too much glucose in your blood. It's important not to stop taking medicines without talking to your doctor first.</p><p>If you have diabetes and you haven't been treated with metformin before, it may be worth discussing this with your doctor, especially if you're overweight.</p>Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-2454982823700326284.post-28457551725964103022009-12-04T14:38:00.000-08:002011-01-20T06:28:26.075-08:00A new diabetic drug scare - sulphonylurea increases the risk of heart disease. Well, hello!!! Diabetes increases the risk of heart disease and of losing eyesight and amputation and stroke. The bloody disease is far worse than the cure.<br /><br />Mind you, quite please I am not taking it at the moment I am on Metformin and Vildagliptin, how long before they say that vildagliptin causes problems and withdraw that?<br /><br />There is a story in the<a href="http://www.nhs.uk/news/2009/12December/Pages/type-II-diabetes-pill-danger-concern.aspx"> NHS here</a>, and it has links to the <a href="http://www.telegraph.co.uk/health/healthnews/6718105/diabetes.html">daily telegraph</a> and <a href="http://www.mirror.co.uk/news/top-stories/2009/12/04/diabetics-in-drugs-scare-115875-21871813/">Daily Mirror</a> stories.Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-2454982823700326284.post-34893490863714910012009-11-22T00:33:00.000-08:002011-01-20T06:28:26.104-08:00<h1>From <a href="http://www.diabeteshealth.com/read/2009/11/20/6452/q-and-a-how-to-lower-your-blood-sugar-when-its-over-200-mgdl-/">Diabetes Health</a><br /></h1><h1><br /></h1><h1>Q & A: How To Lower Your Blood Sugar When It's Over 200 mg/dl </h1> <div style="margin-bottom: 10px; font-size: 0.9em;">Nov 21, 2009 </div> <div class="editorial"> <p><em><strong>Q: </strong>How do I lower my <a class="internal" href="/browse/monitoring/blood-sugar/">blood sugar</a> when it goes over 200 mg/dl? I have <a class="internal" href="/browse/community/type-2-issues/">type 2</a> diabetes.</em><strong> </strong></p> <p><strong>A:</strong> An excellent question, but a complicated one to answer. Your doctor or nurse educator should be contacted whenever your blood sugar runs consistently higher than 250 mg/dl for more than two days. When a person with type 2 diabetes encounters a high blood sugar, the strategy used to bring it down will vary from individual to individual. This is because of differences in treatment involving diet, <a class="internal" href="/browse/fitness/exercise/">exercise</a>, and medication. It will also depend upon the guidelines for glucose control that you and your doctor have mutually agreed upon.</p> <p>When high blood sugars do occur, there are a number of strategies that can be employed to lower the glucose level back down to a normal range. These might include:</p> <p><strong>1) Eating less food at the next meal, eliminating a <a class="internal" href="/browse/food/snacks/">snack</a>, and/or eating foods with a lower <a class="internal" href="/browse/food/glycemic-index-and-carb-counting/">glycemic index</a>.</strong></p> <p>A general rule of thumb to follow is to eliminate 15 grams of <a class="internal" href="/browse/food/low-carb/">carbohydrate</a> (the amount in one starch exchange, one fruit exchange, or one cup of skim milk exchange), which will lower blood glucose by 30 mg/dl. If you test your blood sugar at 182 mg/dl before a meal or snack, then eliminate one starch and one cup of milk at the next meal to bring the glucose value close to 120 mg/dl as a baseline. Although people with diabetes will respond differently to this adjustment, it provides a basic guideline to start with.</p> <p>For persons with type 2 diabetes who are overweight, the loss of only five to 10 percent of total weight can dramatically improve blood glucose values. Consequently, just cutting calories moderately can achieve better blood glucose control.</p> <p>Lastly, choosing foods with a lower glycemic index, that is, foods that do not raise blood sugar as quickly or dramatically, can help to bring blood glucose back into a normal range. Some examples of foods with a low glycemic index are dried beans and lentils.</p> <p>To test the glycemic effect of a food on your system, you will need to do more frequent monitoring. For example, you may want to compare the effect of brown rice versus baked potato by eating equivalent carbohydrate amounts of these foods at <a class="internal" href="/browse/food/dinner/">dinner</a> and comparing your blood glucose response two hours later. The exact effect will vary from person to person.</p> <p><strong>2) Increasing activity or incorporating more exercise.</strong></p> <p>Persons with type 2 diabetes generally respond to increased exercise with a lowered blood glucose value. Simple exercise, such as walking 20 minutes or more per day, can effectively improve glucose tolerance and induce <a class="internal" href="/browse/fitness/weight-loss/">weight loss</a>. Proper exercise can actually be effective enough to lower or completely eliminate the need for medication altogether.</p> <p><strong>3) Increasing medications, changing medications, and/or administering them more frequently.</strong></p> <p>Although this is certainly an option, it makes more sense to first address the problem of elevated blood glucose by exercise and cutting back on food. These measures are less costly and have fewer side effects. If they aren't effective, however, a medication change may be indicated. If you are on the minimal dose of oral agents, your doctor might raise the dose or split it into morning and evening doses.</p> <p>This could also be true for those using <a class="internal" href="/browse/medications/insulin/">insulin</a>. Taking more shots per day does not mean that your diabetes is worse. It may even bring more flexibility into your lifestyle. In fact, a rule of thumb for those on insulin (check with your doctor first before making these adjustments) is to take one unit of regular insulin to lower blood glucose 30 mg/dl. If your blood sugar is 191 mg/dl before a meal, an extra three units of insulin will bring the glucose down about 100 mg/dl.</p> <p>It is important to note that this rule may change for people who exercise regularly because it will take less insulin to achieve the desired effect. It may also change for those who become ill because they are more insulin-resistant and may need more insulin to achieve the desired effect. The effectiveness of insulin is also dramatically decreased by high blood sugar levels.</p> <p><strong>4) Using relaxation techniques and behavioral management.</strong></p> <p>Relaxation exercises, including deep breathing and audio tapes that guide you through deep muscle relaxation, can reduce stress and help you deal more effectively with it. Tapes are available specifically designed to create images of healthiness in diabetic individuals and encourage visualization of improved glucose control. Behavioral management techniques also increase one's overall sense of control over life and self-efficacy, so that diabetes becomes a state of "wellness in the midst of illness." When you are relaxed and in control, your blood glucose values can improve.</p> <p><strong>5) Treating identified illness and/or infections.</strong></p> <p>Illness and infection causes a rise in adrenergic hormones, which increase the production of glucose in the body. This extra surge of glucose is part of the healing process, but can upset glucose control. Thus, continuing to take medications despite poor appetite is vital. You may temporarily require more medication during periods of extended illness. Ask your doctor for instructions on dealing with illness.</p> <p><strong>6) Monitoring on a more frequent basis and/or monitoring other parameters.</strong></p> <p>When your blood glucose values exceed the target ranges established by you and your doctor, monitoring should be done every two hours until your blood glucose returns to normal. This gives you an opportunity to treat and adjust blood glucose as soon as possible, rather than waiting until your next doctor visit or next meal (which might be four or five hours later). It also tells you whether or not what you are doing is helping to bring the blood glucose down. Another step to take if your blood sugar is over 250 mg/dl would be ketone checks (done by urine dip stick or via a fingerstick to measure betahydroxybutyrate, an acid). Testing ketones hourly until they disappear is recommended.</p> <p><strong>7) Increasing consumption of sugar-free fluids.</strong></p> <p>Often, poor hydration accounts for the concentration of sugar in the blood. All people (with diabetes or not) should drink two to three quarts of sugar-free fluids per day. When glucose is elevated, drinking helps to dilute it. Also, drinking fluids is filling, decreasing the possibility of overeating.</p> <p>People with heart disease who take diuretics and those with renal (kidney) complications may need to be on restricted fluids. Check with your doctor and/or dietitian if you fall into these special categories.</p> <p>To combat high blood sugars, the most important strategy is prevention. Prevention of high blood sugars is usually possible with frequent and consistent monitoring. If you have awareness of your usual glucose response patterns to foods and exercise, it will be easier to plan out your day and prevent fluctuations in your blood sugar.</p></div>Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-2454982823700326284.post-5175879802407434112009-11-13T23:43:00.000-08:002011-01-20T06:28:26.149-08:00<h1><span style="font-size:100%;">from <a href="http://www.diabeteshealth.com/">Diabetes Health:</a></span><br /></h1><h1><br /></h1><h1>World Diabetes Day Is This Saturday, November 14, 2009</h1> <div style="font-size: 0.9em; margin-bottom: 10px;"> <strong>Kristin Lund</strong><br /> Nov 12, 2009 </div> <p><strong><a href="http://www.worlddiabetesday.org/">World Diabetes Day</a></strong> is a global awareness campaign that's celebrated every year on November 14. The goal is to encourage action to further the prevention, treatment, and care of diabetes, as well as to support the United Nations Resolution on Diabetes. Landmarks and monuments across the world are lit in blue to create a united voice for diabetes awareness, and diabetes events are held around the globe. As of Monday evening, November 9, the World Diabetes Day website reports that 366 registered diabetes events are scheduled for November 14<sup>th</sup>, in countries ranging from Saudi Arabia to Argentina to Morocco. In addition, 623 monuments are being lit in blue around the globe. More are sure to be added to the list as the day draws closer and closer.</p> <p>The U.N. Resolution on Diabetes focuses world attention on the need to stop the diabetes epidemic through urgent action. <a class="internal" href="http://www.diabeteshealth.com/browse/legal/government-and-policy/">Governments</a> need to promote low-cost strategies that alter diet, increase physical activity, and modify lifestyles in order to reverse the diabetes tide. According to the <a href="http://www.caldiabetes.org/content_display.cfm?contentID=1219&cameFromSearch=yes">California Diabetes Program</a> (DIRC) website, "For governments, [World Diabetes Day] is a call to implement effective strategies and policies for the prevention and management of diabetes to safeguard the health of their citizens with and at risk for diabetes."</p> <p><strong>Advocacy</strong></p> <p>The DIRC and the <a href="http://www.cdc.gov/Features/LivingWithDiabetes/">Centers for Disease Control and Prevention</a> (CDC) have suggestions on how communities can help stop the epidemic, including increasing access to affordable healthy food and <a class="internal" href="http://www.diabeteshealth.com/browse/food/beverages/">beverages</a>. We need to advocate to:</p> <ol><li>Make healthy food and beverages more available and affordable and restrict availability of less healthy foods and beverages in public places such as schools, government buildings, libraries, and parks</li><li>Increase the number of grocery stores in low-income neighborhoods</li><li>Improve mechanisms for purchasing foods directly from local farms</li><li>Offer incentives to retailers to offer healthy food and beverage options</li><li>Limit advertising of less healthy foods and beverages</li><li>Encourage smaller portion sizes by food vendors</li><li>Discourage consumptions of sugar-sweetened beverages</li></ol> <p><strong>Educate someone you know about the risks of diabetes </strong></p> <p>If you are unable to attend a World Diabetes Day event or to witness a monument or building being lit in blue, you can honor the day by educating someone else about the risks of diabetes. They are, according to the DIRC:</p> <ul><li>Family history of diabetes</li><li>Increasing age</li><li>Obesity and a sedentary lifestyle</li><li>Ethnicity</li><li>History of diabetes during <a class="internal" href="http://www.diabeteshealth.com/browse/pregnancy/">pregnancy</a> or giving birth to a large baby</li><li>Having high blood pressure or high <a class="internal" href="http://www.diabeteshealth.com/browse/complications-and-care/lipid-problems/">cholesterol</a></li></ul> <p><strong>Everyone can reduce the risk of <a class="internal" href="http://www.diabeteshealth.com/browse/community/type-2-issues/">type 2</a> diabetes by:</strong></p> <ul><li> Exercising </li><li> Eating right </li><li> Losing weight if needed </li><li> Seeing your healthcare provider </li><li> Getting your eyes checked </li></ul>Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-2454982823700326284.post-3646230485521928722009-11-08T22:56:00.000-08:002011-01-20T06:28:26.176-08:00<a href="http://www.diabeteshealth.com/read/2009/11/07/6438/aace-releases-new-algorithm-for-treatment-of-type-2-diabetes/">http://www.diabeteshealth.com/read/2009/11/07/6438/aace-releases-new-algorithm-for-treatment-of-type-2-diabetes/</a><br /><br />The American Association of Clinical Endocrinologists have bought out new guidelines for the treatment of Type 2. I wonder if the UK guys follow similar guidelines?<br /><br />Meanwhile whilst exploring other diabetes mellitus solutions beyond Metformin I have stumbled across Berberine, there is this report in the <a href="http://www.telegraph.co.uk/news/1525294/Study-shows-how-Chinese-cure-works.html">daily telegraph</a>, and a quick google/bing bought up many other references. The dubiously reliable Wiki has a large sectrion on it <a href="http://en.wikipedia.org/wiki/Berberine">here</a> and it seems to have tremendous benefits, similar in effect to metformin, but with some added side effect benefits, such as inhibiting Stapphylococcus, fungal infections such as Candida, inhibits cancers such as Breast Cancer, and is a mild anti depressant. Looks like a wonder herb to me, yet a quick trawl of health foods shops doesn't readily find it listed. interesting?<br /><br />Wonder if I should give it serious consideration and perhaps import it from China?Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-2454982823700326284.post-35990352000869586812009-10-29T00:23:00.000-07:002011-01-20T06:28:26.206-08:00“Diabetes UK recommends that people with diabetes without known cardiovascular disease should discuss their individual risk with their healthcare team," said Libby Dowling, Care Advisor for Diabetes UK.<br /><br />So this is a change in guidelines, I have been on Aspirin since 2006 and I must admit, I bleed like a stuck pig when ever I cut myself (rarely) or do a prick test (frequently). I thought that was good, when I was first diagnosed I used to have the devils own game squeezing the thick gooey blood out of my finger - completely the opposite now.<br /><br />From a purely non scientific, not knowing what I am talking about, I prefer blood that flows easily !!<br /><br />read <a href="http://www.diabetes.org.uk/About_us/News_Landing_Page/Diabetes-UKs-new-aspirin-guidelines/">more here</a>Unknownnoreply@blogger.com0tag:blogger.com,1999:blog-2454982823700326284.post-77894652956394685192009-10-22T14:38:00.000-07:002011-01-20T06:28:26.253-08:00And in the UK they have stopped our strips for monitoring. Utter Madness. The following came from Diabetes Health.<br /><br /><h1>Never a "Duh!" Moment: Study Confirms That Self-Monitoring Improves Patients' Response to Diabetes</h1> <div style="font-size: 0.9em; margin-bottom: 10px;"> <strong>Patrick Totty</strong><br /> Oct 13, 2009 </div> <p>"Self-monitoring blood glucose" (SMBG), a staple in the lives of most people with diabetes who take <a class="internal" href="http://www.diabeteshealth.com/browse/medications/insulin/">insulin</a>, involves consistently monitoring and recording blood glucose levels before and after specific activities, such as eating, exercising, sleeping, and taking insulin. By observing the effects of certain foods and activities on their blood glucose levels, patients can learn exactly what works to raise or lower them. Thus, SMBG affords a kind of "fine tuning" approach to diabetes that empowers patients to adjust their medicine, modify their behavior, and manage their disease without always needing expert intervention. </p> <p>So it's hardly surprising that an international study sponsored by Roche Diagnostics has confirmed that SMBG is a useful tool.</p> <p>The study, published by SAGE Publications in <em>The Diabetes Educator</em>, looked at the SMBG practice of "paired testing," in which people with diabetes measure their blood glucose levels before and after specific activities to see how modifications in those activities might lead to better BG management. The researchers, located in five far-flung locations-Los Angeles, London, New Delhi, Singapore, and Washington, DC-found that SMBG is helpful to patients because it increases their sense of control and provides nuanced information that allows them to finely hone their diabetes management.</p> <p>The researchers also looked into the possibility that non-insulin-taking <a class="internal" href="http://www.diabeteshealth.com/browse/community/type-2-issues/">type 2s</a> could benefit from SMBG. Because about 40 percent of type 2 patients are treated with oral drugs or through diet, constant self-monitoring of blood glucose has not been thought to be necessary. Even type 2s who take a combination of oral medications and a daily dose of long-acting insulin are not required to take anywhere near the number of self-administered BG tests that SMBG usually calls for. Given the depth of information and sense of control that SMBG affords, however, even type 2s who do not use insulin may soon hear their healthcare professionals recommending SMBG as part of an aggressive approach to managing type 2.</p>Unknownnoreply@blogger.com0